ACQUISITION OF VISION HEALTHCARE BUSINESS

28 juli 2016

The Vemedia Group announced today that it has reached an agreement with the Damier Group on the acquisition of the Vision Healthcare business by Vemedia Consumer Health.

The Vision Healthcare business is known for its brands Vision, Ecosym, Luuf, Glucadol and Zinolium.

Yvan Vindevogel, CEO of Damier Group says: “The acquisition of the Vision Healthcare business by Vemedia Consumer Health will enable the company to continue its plans for expansion and roll-out of the brands. With the support of the marketing and sales teams of Vemedia, Vision Healthcare has a bright future ahead. ”

Rob Drenth, CEO of Vemedia Consumer Health says: “We are happy to extend our brand portfolio with the various brands of Vision Healthcare. We are convinced that we can further build the brands and even strengthen their market positions. ”

Completion of the transaction is foreseen on 30 September 2016 or shortly thereafter.

LEES OOK
IK INVESTMENT PARTNERS TO SELL VEMEDIA TO CHARTERHOUSE CAPITAL PARTNERS LLP
28 juli 2016
The Vemedia Group announced today that its majority shareholder IK Investment Partners has reached an agreement to sell the Vemedia Group to an entity ultimately owned by Charterhouse Capital Partners LLP and which also owns La Coopération Pharmaceutique, a leading French OTC drug manufacturer and distributor. The Parties have agreed not to disclose the financial terms of the transaction.
VEMEDIA CONSUMER HEALTH ACQUIRES STARDEA
19 februari 2016
Vemedia Consumer Health is pleased to announce the acquisition of Stardea, a fast growing Consumer Healthcare company in Italy. Financial terms are not disclosed. The acquisition of Stardea follows the acquisition of Oenobiol earlier this month.